Jan 16, 2025 | Case Study, Case Study Forecasting
A multinational pharmaceutical firm asked Ozmosi to provide forecasts to assess the market impact of delays in delivering new formulation and packaging for an existing product. A planned reformulation seen as necessary to preserving market share had been delayed for...
Jan 16, 2025 | Case Study, Case Study Forecasting, Case Study Portfolio
The oncology team of a major multinational pharmaceutical company asked Ozmosi to provide additional forecasting support for a newly acquired product. They needed to update and validate the current forecast models to identify the most effective development strategies...
Jan 16, 2025 | Case Study, Case Study Forecasting
The Children’s Hospital of Philadelphia–Policy Lab approached Ozmosi for help in supporting its application for federal funding to establish a new organizational structure to better support children in the Philadelphia foster care system. The proposed structure was...
Jan 16, 2025 | Case Study, Case Study Portfolio
When a pharmaceutical company in China realized it needed outside help to identify and close the gaps in its R&D portfolio, its leaders turned to Ozmosi for a complete, bottom-up portfolio management solution. The company was missing key data for many of its...
Jan 16, 2025 | Cancer, Industry Trends
LUNG CANCER SCREENING UPDATE: As of February 5, 2015, effective immediately, Medicare will cover lung cancer screening by low-dose CT. ORIGINAL POST – Dec. 1, 2014 The Centers for Medicare & Medicaid Services (CMS) recently issued a proposal for Medicare to cover...
